Gene

ATL1 - autosomal dominant spastic paraplegia type 3A

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 1070

ATL1 - autosomal dominant spastic paraplegia type 3A



€ 1070

ATL1 - autosomal dominant spastic paraplegia type 3A

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is often ordered in combination with:

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)

OMIM: 606439
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 1070
Gene

BSCL2 - autosomal dominant spastic paraplegia type 17 (Silver syndrome)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 542

BSCL2 - autosomal dominant spastic paraplegia type 17 (Silver syndrome)



€ 542

BSCL2 - autosomal dominant spastic paraplegia type 17 (Silver syndrome)

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries
Remarks
Only two specific mutations in exon 3 of the BSCL2 gene have been described in Silver syndrome. Therefore only this exon is analyzed.

OMIM: 606158
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 542
Gene

HSPD1 - autosomal dominant spastic paraplegia type 13

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 665

HSPD1 - autosomal dominant spastic paraplegia type 13



€ 665

HSPD1 - autosomal dominant spastic paraplegia type 13

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 118190
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 665
Gene

KIF1A - autosomal dominant spastic paraplegia type 30

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 1081

KIF1A - autosomal dominant spastic paraplegia type 30



€ 1081

KIF1A - autosomal dominant spastic paraplegia type 30

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 614255
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 1081
Gene

KIF5A - autosomal dominant spastic paraplegia type 10

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 789

KIF5A - autosomal dominant spastic paraplegia type 10



€ 789

KIF5A - autosomal dominant spastic paraplegia type 10

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 602821
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 789
Gene

NIPA1 - autosomal dominant spastic paraplegia type 6

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 598

NIPA1 - autosomal dominant spastic paraplegia type 6



€ 598

NIPA1 - autosomal dominant spastic paraplegia type 6

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 608145
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 598
Gene

REEP1 - autosomal dominant spastic paraplegia type 31

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 991

REEP1 - autosomal dominant spastic paraplegia type 31



€ 991

REEP1 - autosomal dominant spastic paraplegia type 31

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)

OMIM: 609139
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 991
Gene

RTN2 - autosomal dominant spastic paraplegia type 12

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 632

RTN2 - autosomal dominant spastic paraplegia type 12



€ 632

RTN2 - autosomal dominant spastic paraplegia type 12

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 603183
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 632
Gene

SLC33A1 - autosomal dominant spastic paraplegia

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 609

SLC33A1 - autosomal dominant spastic paraplegia



€ 609

SLC33A1 - autosomal dominant spastic paraplegia

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 603690
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 609
Gene

SPAST - autosomal dominant spastic paraplegia type 4 (SPG4)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 915

SPAST - autosomal dominant spastic paraplegia type 4 (SPG4)



€ 915

SPAST - autosomal dominant spastic paraplegia type 4 (SPG4)

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is often ordered in combination with:

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)

OMIM: 604277
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 915
Gene

TGM6 - autosomal dominant spastic paraplegia

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 665

TGM6 - autosomal dominant spastic paraplegia



€ 665

TGM6 - autosomal dominant spastic paraplegia

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 613900
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 665
Gene

WASHC5 (KIAA0196)- autosomal dominant spastic paraplegia type 8

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 834

WASHC5 (KIAA0196)- autosomal dominant spastic paraplegia type 8



€ 834

WASHC5 (KIAA0196)- autosomal dominant spastic paraplegia type 8

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 610657
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 834
MLPA

ATL1 - autosomal dominant spastic paraplegia type 3A (MLPA)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 609

ATL1 - autosomal dominant spastic paraplegia type 3A (MLPA)



€ 609

ATL1 - autosomal dominant spastic paraplegia type 3A (MLPA)

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is often ordered in combination with:

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Deletion/duplication analysis (MLPA)

OMIM: 606439
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 609
MLPA

SPAST - autosomal dominant spastic paraplegia type 4 (SPG4) (MLPA)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 609

SPAST - autosomal dominant spastic paraplegia type 4 (SPG4) (MLPA)



€ 609

SPAST - autosomal dominant spastic paraplegia type 4 (SPG4) (MLPA)

This test is available for the following conditions:

  • Conditions > Neurological > Spastic paraplegia, autosomal dominant

This product is often ordered in combination with:

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Deletion/duplication analysis (MLPA)

OMIM: 604277
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 609